For patients, it is an indicator of effective improvement in cardiac function which, in turn, is reflected in a change for the better in the quality of their everyday life.
Heart failure is increasingly common and is costly to treat.
Keeping patients out of hospital by use of effective medication, ie beta-blockade, has enormous potential for achieving savings in healthcare provision. By the end of the study the majority of patients were receiving 200 mg daily. Differences in drug treatment of chronic heart failure between European countries. The role of beta receptor blockade in preventing sudden death. All rights reserved.